FindTrial
Sign In

Study on the diagnosis and treatment strategy of influenza A combined with traditional Chinese and Western medicine

Study on the strategy of diagnosis and treatment of new acute respiratory diseases with integrated Chinese and Western medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000466
Enrollment
Unknown
Registered
2024-09-22
Start date
2018-05-20
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza A

Interventions

treatment group:shufengjiebiao formula
oseltamivir group:oseltamivir

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years old; 2. Acute onset (=10 days); 3. Armpit body temperature =38?; 4. Cough symptoms; 5. Participants who voluntarily participate in this study can complete all follow-up contents and sign informed consent according to the protocol requirements.

Exclusion criteria

Exclusion criteria: 1. Those who have mental illness and cannot express their wishes clearly; 2. Subjects or their family members may give up treatment. 3. According to the previous test results exclude respiratory infectious diseases; The investigator believes that sample collection may affect the subject's prognosis or the investigator believes that the subject will not complete the study.

Design outcomes

Primary

MeasureTime frame
Body temperature recovery rate;the comparison of symptom disappearance rate;the negative conversion rate of influenza A virus;—

Secondary

MeasureTime frame
Gene test;—

Countries

China

Contacts

Public ContactHONGZHOU LU

Shanghai Public Health Clinical Center

luhongzhou@fudan.edu.cn18917763257

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026